{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T05:18:09Z","timestamp":1782278289935,"version":"3.54.5"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,9]]},"abstract":"<jats:p>Thymic carcinoma represents a rare and poorly understood type of thymic epithelial neoplasm that has been the subject of much controversy. Poorly differentiated nonkeratinizing squamous cell carcinoma, also known as lymphoepithelioma-like thymic carcinoma, is a rare variant of thymic carcinoma that has not been adequately characterized in the literature. The clinicopathologic, immunohistochemical, ultrastructural, and molecular features of 25 cases are reported. The patients were 19 men and 6 women, ranging in age from 20 to 85 years (mean: 60\u2009y). The tumors presented clinically as anterior mediastinal masses with chest pain and shortness of breath or were found incidentally on imaging studies. Tumor size ranged from 2.0 to 13.5\u2009cm in greatest diameter. Most of the tumors were small, well-circumscribed and confined to the mediastinum. Five cases presented with large, bulky, and infiltrative masses. Histologically, the hallmark of these tumors was a neoplastic proliferation of large, round to oval cells with vesicular nuclei, prominent eosinophilic nucleoli, and scant cytoplasm. Two histologic growth patterns were identified: tumors with a heavy lymphoplasmacytic stroma (lymphoepithelioma-like pattern), and tumors showing abundant desmoplastic stroma (desmoplastic pattern). Immunohistochemical stains showed strong positivity of the tumor cells for cytokeratin AE1\/AE3, CK5\/6, CK18, MOC31, p16, p40, and p63. MIB-1 showed on average 35% nuclear positivity. CD117 was positive in 21\/25 cases and CD5 in 20\/25 cases. Epstein-Barr encoded RNA in situ hybridization was positive in only 1 case. Electron microscopy in 4 cases showed primitive round to oval cells with prominent nucleoli, scant cytoplasm and immature cell junctions. Molecular features were studied by next-generation sequencing using high quality sequence data obtained from 18 patients. Variants with allele frequency between 5% and 45% and quality scores &gt;50 were classified as somatic. A total of 16\/18 cases had one or more somatic variants of unknown significance. One case showed an IDH1 p. R132C mutation, also of unknown significance. No \u201cactionable\u201d genes amenable to currently available targeted therapies were identified in this cohort. Clinical follow-up was obtained in 20 patients; 14 patients were alive and well with no evidence of disease between 1.5 and 16 years after diagnosis (median survival: 4\u2009y; mean: 5.5\u2009y). Most survivors had relatively small tumors (&lt;5\u2009cm. diameter), were in stage I and II at diagnosis and showed clear surgical margins. Five patients died of their tumors with metastases to bone, brain, chest wall, lungs and lymph nodes; all were in advanced stages and showed positive margins. Prognosis for these tumors appears to be correlated with the staging and status of the margins at the time of initial surgery.<\/jats:p>","DOI":"10.1097\/pas.0000000000001101","type":"journal-article","created":{"date-parts":[[2018,7,3]],"date-time":"2018-07-03T23:14:22Z","timestamp":1530659662000},"page":"1224-1236","source":"Crossref","is-referenced-by-count":19,"title":["Poorly Differentiated Nonkeratinizing Squamous Cell Carcinoma of the Thymus"],"prefix":"10.1097","volume":"42","author":[{"given":"David","family":"Suster","sequence":"first","affiliation":[{"name":"Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"German","family":"Pihan","sequence":"additional","affiliation":[{"name":"Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander C.","family":"Mackinnon","sequence":"additional","affiliation":[{"name":"Department of Pathology, Medical College of Wisconsin, Milwaukee, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saul","family":"Suster","sequence":"additional","affiliation":[{"name":"Department of Pathology, Medical College of Wisconsin, Milwaukee, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230922","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/1097-0142(19910215)67:4<1025::AID-CNCR2820670427>3.0.CO;2-F","article-title":"Thymic carcinoma. A clinicopathologic study of 60 cases","volume":"67","author":"Suster","year":"1991","journal-title":"Cancer"},{"key":"R2-20230922","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1053\/j.semdp.2006.02.006","article-title":"Thymic carcinoma: update of current diagnostic criteria and histologic types","volume":"22","author":"Suster","year":"2005","journal-title":"Semin Diagn Pathol"},{"key":"R4-20230922","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3960\/jslrt.53.9","article-title":"The evaluation of immunohistochemical markers and thymic cortical microenvironmental cells in distinguishing thymic carcinoma from type B3 thymoma or lung squamous cell carcinoma","volume":"53","author":"Hayashi","year":"2013","journal-title":"J Clin Exp Hematop"},{"key":"R5-20230922","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.3892\/ol.2014.2475","article-title":"Clinical outcome of thymic lymphoepithelioma-like carcinoma: case report of a 14-year-old male","volume":"8","author":"Sekihara","year":"2014","journal-title":"Oncol Lett"},{"key":"R6-20230922","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3892\/mco.2016.803","article-title":"Response to chemotherapy with carboplatin plus albumin-bound paclitaxel in a patient with lymphoepithelioma-like thymic carcinoma: a case report","volume":"4","author":"Shima","year":"2016","journal-title":"Mol Clin Oncol"},{"key":"R7-20230922","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00428-013-1371-y","article-title":"Thymic carcinomas: clinicopathologic study of 37 cases from a single institution","volume":"462","author":"Thomas de Montpr\u00e9ville","year":"2013","journal-title":"Virchows Arch"},{"key":"R8-20230922","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1309\/AJCP88FZTWANLRCB","article-title":"Thymic carcinoma, part 1: a clinicopathologic and immunohistochemical study of 65 cases","volume":"138","author":"Weissferdt","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"R9-20230922","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/ejcts\/ezw107","article-title":"Comparison of outcomes between neuroendocrine thymic tumours and other subtypes of thymic carcinomas: a joint analysis of the European Society of Thoracic Surgeons and the International Thymic Malignancy Interest Group","volume":"50","author":"Filosso","year":"2016","journal-title":"Eur J Cardiothorac Surg"},{"key":"R10-20230922","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/JTO.0000000000000128","article-title":"Thymic carcinoma: a cohort study of patients from the European society of thoracic surgeons database","volume":"9","author":"Ruffini","year":"2014","journal-title":"J Thorac Oncol"},{"key":"R11-20230922","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1515\/cclm-2013-0883","article-title":"Routine use of the Ion Torrent ApliseqTM Cancer Hotspot Panel for identification of clinically actionable somatic mutations","volume":"52","author":"Tsongalis","year":"2014","journal-title":"Clin Chem Lab Med"},{"key":"R12-20230922","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1440-1827.1994.tb02936.x","article-title":"A review of 79 thymomas. Modification of staging system and reappraisal of conventional division into invasive and non-invasive thymoma","volume":"44","author":"Koga","year":"1994","journal-title":"Pathol Int"},{"key":"R13-20230922","doi-asserted-by":"crossref","first-page":"901","DOI":"10.21037\/jtd.2016.03.53","article-title":"Prognostic stratification of thymic epithelial tumors based on both Masaoka-Koga stage and WHO classification systems","volume":"8","author":"Lee","year":"2016","journal-title":"J Thorac Dis"},{"key":"R14-20230922","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jtcvs.2014.09.124","article-title":"Thymic carcinoma outcomes and prognosis: results of an international analysis","volume":"149","author":"Ahmad","year":"2015","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R15-20230922","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ejca.2007.11.004","article-title":"Thymic epithelial tumors: a population-based study of the incidence, diagnostic procedures and therapy","volume":"1","author":"de Jong","year":"2008","journal-title":"Eur J Cancer"},{"key":"R16-20230922","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF01612643","article-title":"Thymic carcinoma","volume":"116","author":"Hartmann","year":"1990","journal-title":"J Cancer Res Clin Oncol"},{"key":"R17-20230922","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1097\/MPH.0b013e31802d3a83","article-title":"Thymic lymphoepithelioma like carcinoma in children: clinicopathologic features and molecular analysis","volume":"28","author":"Hsueh","year":"2006","journal-title":"J Pediatr Hematol Oncol"},{"key":"R18-20230922","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1080\/08880010050211420","article-title":"Thymic carcinoma, systemic lupus erythematosus, and hypertrophic pulmonary osteoarthropathy in an 11-year-old boy: a novel association","volume":"17","author":"Di Cataldo","year":"2000","journal-title":"Pediatr Hematol Oncol"},{"key":"R19-20230922","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s00467-007-0666-0","article-title":"Lymphoepithelioma-like thymic carcinoma in a 16-year-old boy with nephrotic syndrome\u2014a case report","volume":"23","author":"Kili\u015b-Pstrusi\u0144ska","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"R20-20230922","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1378\/chest.128.1.140","article-title":"Immunohistochemical KIT (CD117) expression in thymic epithelial tumors","volume":"128","author":"Nakagawa","year":"2005","journal-title":"Chest"},{"key":"R21-20230922","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/path.1514","article-title":"KIT (CD117) is frequently overexpressed in thymic carcinomas but is absent in thymomas","volume":"202","author":"Pan","year":"2004","journal-title":"J Pathol"},{"key":"R22-20230922","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.21037\/jtd.2016.08.82","article-title":"Prognostic value of immunohistochemical markers in malignant thymic epithelial tumors","volume":"8","author":"Leisibach","year":"2016","journal-title":"J Thorac Dis"},{"key":"R23-20230922","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2559.2004.01796.x","article-title":"Thymic carcinoma: a clinicopathological and immunohistological study of 19 cases","volume":"44","author":"Chalabreysse","year":"2004","journal-title":"Histopathology"},{"key":"R24-20230922","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13000-015-0441-7","article-title":"Differential diagnostic value of CD5 and CD117 expression in thoracic tumors: a large-scale study of 1465 non-small cell lung cancer cases","volume":"10","author":"Kriegsmann","year":"2015","journal-title":"Diagn Pathol"},{"key":"R25-20230922","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/ajcp\/111.2.235","article-title":"Immunoreactivity of a new CD5 antibody with normal epithelium and malignant tumors including thymic carcinoma","volume":"111","author":"Tateyama","year":"1999","journal-title":"Am J Clin Pathol"},{"key":"R26-20230922","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1097\/00000478-199612000-00006","article-title":"Primary thymic epithelial neoplasms showing combined features of thymoma and thymic carcinoma: a clinicopathologic study of 22 cases","volume":"20","author":"Suster","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"R27-20230922","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0046-8177(98)90112-5","article-title":"Neuroendocrine differentiation in thymic epithelial tumors with special reference to thymic carcinoma and atypical thymoma","volume":"29","author":"Hishima","year":"1998","journal-title":"Hum Pathol"},{"key":"R28-20230922","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1097\/00000478-199809000-00003","article-title":"Neuroendocrine differentiation is a common feature of thymic carcinoma","volume":"22","author":"Lauriola","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"R29-20230922","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/ajcp\/aqv095","article-title":"Neuroendocrine differentiation in thymic carcinomas: a diagnostic pitfall. An immunohistochemical analysis of 27 cases","volume":"145","author":"Weissferdt","year":"2016","journal-title":"Am J Clin Pathol"},{"key":"R30-20230922","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0936-6555(05)80041-X","article-title":"Nasopharyngeal carcinoma with metastatic disease to mediastinal and hilar lymph nodes: an indication for more aggressive therapy","volume":"8","author":"Kwan","year":"1996","journal-title":"Clin Oncol"},{"key":"R31-20230922","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1034\/j.1600-0463.2000.d01-74.x","article-title":"Absence of latent Epstein-Barr virus in thymic epithelial tumors as demonstrated by Epstein-Barr-encoded RNA (EBER) in situ hybridization","volume":"108","author":"Engel","year":"2000","journal-title":"APMIS"},{"key":"R32-20230922","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.lungcan.2016.01.004","article-title":"Medical treatment involving investigational drugs and genetic profile of thymic carcinoma","volume":"93","author":"Asao","year":"2016","journal-title":"Lung Cancer"},{"key":"R33-20230922","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1093\/carcin\/bgx094","article-title":"The genomic and epigenomic landscape in thymic carcinoma","volume":"38","author":"Saito","year":"2017","journal-title":"Carcinogenesis"},{"key":"R34-20230922","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.lungcan.2014.08.020","article-title":"Genetic profiling of thymic carcinoma using targeted next-generation sequencing","volume":"86","author":"Shitara","year":"2014","journal-title":"Lung Cancer"},{"key":"R35-20230922","doi-asserted-by":"crossref","first-page":"6337","DOI":"10.2147\/OTT.S108749","article-title":"Rare frequency of gene variation and survival analysis in thymic epithelial tumors","volume":"9","author":"Song","year":"2016","journal-title":"Onco Targets Ther"},{"key":"R36-20230922","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13019-016-0468-1","article-title":"Tumor-related gene expression levels in thymic carcinoma and Type B3 thymoma","volume":"11","author":"Karube","year":"2016","journal-title":"J Cardiothorac Surg"},{"key":"R37-20230922","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1126\/science.1236062","article-title":"An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells","volume":"340","author":"Rohle","year":"2013","journal-title":"Science"},{"key":"R38-20230922","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nrc3343","article-title":"The role of mutations in epigenetic regulators in myeloid malignancies","volume":"12","author":"Shih","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"R39-20230922","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2147\/JBM.S70716","article-title":"IDH1 and IDH2 mutations as novel therapeutic targets: current perspectives","volume":"7","author":"Mondesir","year":"2016","journal-title":"J Blood Med"},{"key":"R40-20230922","doi-asserted-by":"crossref","first-page":"7336","DOI":"10.1038\/srep07336","article-title":"Mutations of epigenetic regulatory genes are common in thymic carcinomas","volume":"4","author":"Wang","year":"2014","journal-title":"Sci Rep"},{"key":"R41-20230922","doi-asserted-by":"crossref","first-page":"e13821","DOI":"10.1371\/journal.pone.0013821","article-title":"FGFR3, HRAS, KRAS, NRAS and PIK3CA mutations in bladder cancer and their potential as biomarkers for surveillance and therapy","volume":"5","author":"Kompier","year":"2010","journal-title":"PLoS ONE"},{"key":"R42-20230922","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1038\/sj.onc.1204465","article-title":"Deregulated FGFR3 mutants in multiple myeloma cell lines with t(4;14): comparative analysis of Y373C, K650E and the novel G384D mutations","volume":"20","author":"Ronchetti","year":"2001","journal-title":"Oncogene"},{"key":"R43-20230922","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/ng.3016","article-title":"Specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors","volume":"46","author":"Petrini","year":"2014","journal-title":"Nat Genet"},{"key":"R44-20230922","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.lungcan.2017.05.020","article-title":"GTF2I mutation frequently occurs in more indolent thymic epithelial tumors and predicts better prognosis","volume":"110","author":"Feng","year":"2017","journal-title":"Lung Cancer"},{"key":"R45-20230922","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ccell.2018.01.003","article-title":"The integrated genomic landscape of thymic epithelial tumors","volume":"33","author":"Radovich","year":"2018","journal-title":"Cancer Cell"},{"key":"R46-20230922","doi-asserted-by":"crossref","first-page":"4855","DOI":"10.1158\/1078-0432.CCR-17-0066","article-title":"Genomic analysis of thymic epithelial tumors identifies novel subtypes associated with distinct clinical features","volume":"23","author":"Lee","year":"2017","journal-title":"Clin Cancer Res"},{"key":"R47-20230922","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1053\/j.semdp.2006.02.006","article-title":"Thymic carcinoma: update of current diagnostic criteria and histologic types","volume":"22","author":"Suster","year":"2005","journal-title":"Semin Diagnost Pathol"},{"key":"R48-20230922","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1093\/ajcp\/111.6.826","article-title":"Thymoma, atypical thymoma, and thymic carcinoma: a novel conceptual approach to the classification of thymic epithelial neoplasms","volume":"111","author":"Suster","year":"1999","journal-title":"Am J Clin Pathol"},{"key":"R49-20230922","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.hoc.2008.03.001","article-title":"Classification of thymoma: the WHO and beyond","volume":"22","author":"Suster","year":"2008","journal-title":"Hematol Oncol Clin N Am"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00000478-201809000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T22:29:43Z","timestamp":1695421783000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201809000-00011"}},"subtitle":["Clinicopathologic and Molecular Genetic Study of 25 Cases"],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":48,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001101","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]}}}